Uterine Artery Ligation at Origin in Total Laparscopic Hystrectomy

Launched by AIN SHAMS UNIVERSITY · Mar 19, 2021

Keywords

ClinConnect Summary

1. Approval of the study protocol will be sought from ASUMH ethical committee.
2. The patients will be enrolled from the outpatient gynecology clinic of ASUMH.
3. History, examination and routine investigations will be done to identify eligible patients.
4. Written informed consent will be sought from the patients after proper counseling.
5. Randomization: It will be a quasi-randomized clinical trial.
6. Allocation: through "Alternation" method. Eligible patients will be randomized into one of the two study groups, where odd numbered patients (ex: patient number 1, 3, 5, etc. ...) will be a...

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • 1. Age group (35-70 years old).
• • 2. Women consenting to have a total laparoscopic hysterectomy.
• Exclusion Criteria:
• • 1. Patients with relative contraindication to general anesthesia (e.g. chronic liver cell failure)(All laparoscopic procedures are done under GA).
• • 2. Patients with contraindication to laparoscopic surgery (e.g. severe cardio-pulmonary dysfunction).
• • 3. Bleeding tendency (e.g. anticoagulants, platelets disorders)(will affect the blood loss measurement)
• • 4. Body mass index more than 35 Kg/m2(not suitable for laparoscopic surgeries as obesity affects airway pressure )
• 5. Uncorrected anemic patients (Hemoglobin \< 10 gm. /dl).(will affect the outcomes eg :
• • Blood transfusion , hospital stay ... etc )